| Literature DB >> 27325285 |
Rui Zhang1, Zhenying Han1, Vincent Degos1,2, Fanxia Shen1, Eun-Jung Choi1, Zhengda Sun3, Shuai Kang1, Michael Wong1, Wan Zhu1, Lei Zhan1, Helen M Arthur4, S Paul Oh5, Marie E Faughnan6, Hua Su1.
Abstract
An abnormally high number of macrophages are present in human brain arteriovenous malformations (bAVM) with or without evidence of prior hemorrhage, causing unresolved inflammation that may enhance abnormal vascular remodeling and exacerbate the bAVM phenotype. The reasons for macrophage accumulation at the bAVM sites are not known. We tested the hypothesis that persistent infiltration and pro-inflammatory differentiation of monocytes in angiogenic tissues increase the macrophage burden in bAVM using two mouse models and human monocytes. Mouse bAVM was induced through deletion of AVM causative genes, Endoglin (Eng) globally or Alk1 focally, plus brain focal angiogenic stimulation. An endothelial cell and vascular smooth muscle cell co-culture system was used to analyze monocyte differentiation in the angiogenic niche. After angiogenic stimulation, the Eng-deleted mice had fewer CD68(+) cells at 2 weeks (P = 0.02), similar numbers at 4 weeks (P = 0.97), and more at 8 weeks (P = 0.01) in the brain angiogenic region compared with wild-type (WT) mice. Alk1-deficient mice also had a trend toward more macrophages/microglia 8 weeks (P = 0.064) after angiogenic stimulation and more RFP(+) bone marrow-derived macrophages than WT mice (P = 0.01). More CD34(+) cells isolated from peripheral blood of patients with ENG or ALK1 gene mutation differentiated into macrophages than those from healthy controls (P < 0.001). These data indicate that persistent infiltration and pro-inflammatory differentiation of monocytes might contribute to macrophage accumulation in bAVM. Blocking macrophage homing to bAVM lesions should be tested as a strategy to reduce the severity of bAVM.Entities:
Keywords: Angiogenesis; Animal models; Arteriovenous malformations; Cerebrovascular disease; Macrophages; Microglia
Mesh:
Substances:
Year: 2016 PMID: 27325285 PMCID: PMC5029790 DOI: 10.1007/s10456-016-9519-4
Source DB: PubMed Journal: Angiogenesis ISSN: 0969-6970 Impact factor: 9.596